peripheral arterial disease, peripheral vascular disease
TRANSCRIPT
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
1/31
Q.C.G. Oxorbkso @riup
Iutbido Cugkt
Qrcgoop Beibfclkj`cd
Rojkir Qeyskiteorcpkst
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
2/31
Jito
Weks cugkt wcs prosojtog kj Jirte-Ocst
^o`kijcl Xcsbulcr Bijhorojbo ct Hroodcj
Eispktcl, Jowbcstlo upij Wyjo, _.F ij
Jivodnor >118.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
3/31
Ckd ih teks cugkt
Wi hkjg iut teo hocsknklkty & ovkgojbo noekjg
teo jow iutbido docsuros.
Wi cssoss teo ohhobtkvojoss ih teo jow
iutbido docsuros.
Wi cjclyso teo ohhobtkvojoss ih teo oxorbkso
`riup.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
4/31
Q.X.G ir Q.C.G 9
Weo Kjtordkttojt Blcugkbctkij (K.B) ks bcusog
ny teo cteorisblorisks ih teo crtorkos ih liwor
lkdns. (Ekctt P^ ot cl 3;;1)
Xcsbulcr ks c `lincl tord wekbe kjblugos
crtorkos cjg vokjs.
Cs K.B ks bcusog ny teo gksocso ih teocrtorkos, Qorkpeorcl Crtorkcl Gksocso (Q.C.G) ks
teo cppriprkcto tord.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
5/31
Pey Oxorbkso `riup hir Q.C.G9
^o`ulcr oxorbksos kdprivos teo wclfkj`
cnklkty cjg golcys teo ijsot ih blcugkbctkij
pckj.
Oxorbkso ks cj kjto`rcl pcrt ih Q.C.G
troctdojt.
Ruporvksog oxorbkso ks suporkir tecj teo
eido ncsog oxorbkso pri`rcddo.
(Ekrsbe CW ot cl >118, Loj` @B ot cl >111 & Nojgordcbeor NLP ot cl >118)www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
6/31
Pect pcrtkbkpcjts gi 9
Kts c sovoj woof oxorbkso pri`rcddo, twi
sosskijs por woof
Hkrst cjg lcst blcssos gogkbctog hir Qro &
Qist roecn sunmobtkvo & inmobtkvo
cssossdojt/gctc billobtkij.
3> gkhhorojt oxorbkso stctkijs. Qcrtkbkpcjtswirf ct ocbe stctkij hir hkvo dkjutos hir
cpprix 7? dkjutos.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
7/31
Pects Jow 9
Kjtrigubog jow Ovkgojbo Ncsog Inmobtkvo &
Runmobtkvo iutbido docsuros.
Inmobtkvo= 8-Dkjuto Pclf Wost.
Runmobtkvo= Pclfkj` Kdpckrdojt
Suostkijjckro.
Jow Gctcncso ti billobt cjg cjclyso gctc
qukbfor & cbburcto.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
8/31
Pey 8-DPW tecj Wrocgdkll 9
Rojsktkvo, Rcho, Rkdplo & Bist ohhobtkvo.
8 DPW ks teo nost cltorjctkvo ti teo Wrocgdkll
Wost & oquclly sojsktkvo. Wrocgdkll tost dcy jit rohlobt gckly cbtkvkty.
Diro cbboptcnlo ny Ilgor poiplo cs wclfkj`
ks c gcy ti gcy cbtkvkty.
Ruktcnlo hir teo biddujkty sotup.
(Ojrk`et QL ot cl >112, Rbeoror RC >117, Ietcfo QM >11?, Dijt`idory QR ot cl 3;;5)
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
9/31
Pey P.K.S tecj RH28 9
Gksocso spobkhkb.
Rkdplo cjg strck`et hirwcrg.
Ocsy ti bidploto bidpcrog ti RH-28.
Kjhirdctkvo cjg cnlo ti cssoss teo pctkojts
pikjt ih vkow.
Cnlo ti cssoss iteor lkdktkj` hcbtirs.
(^o`ojstokjor M@ ot cl 3;;1, Rbeoror RC >117)
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
10/31
Weo @riup
Judnor ih `riups kjblugog kj teks cugkt 4 2
Witcl judnor ih pcrtkbkpcjts robruktog ti teks
teroo `riups 4 2>
Witcl judnor ih pcrtkbkpcjts bidplotog teo
sovoj woof pri`rcddo 4 >? 05%
Witcl judnor ih grip-iuts 4 0 >>%
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
11/31
Weo @riup
Rox rctki= >.? Dclo=3 Hodclo
Cvorc`o c`o= 01 [ocrs
Cvorc`o eok`et= 303 Bojtodotors
Cvorc`o wok`et= 50 Fkli`rcdos
Cvorc`o 0?% ih progkbtog dcxkdud
8-DPG= 22> Dotors (Ojrk`et QL ot cl >112)
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
12/31
Blcugkbctkij Gkstcjbo
38?
301
30?
351
35?
Blcugkbctkij Gkstcjbo
Qro
Qist
Cvorc`o Qro roecn (8DPW) = 30> Dotors
Cvorc`o Qist roecn (8DPW) = 357 Dotors
(Gkhhorojbo= +3> Dotors I^ +>7%)www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
13/31
Qro & Qist roecn Blcugkbctkij
Gkstcjbo Gkhhorojbo ny %
Goblkjo
Ji Becj`o
Kdprivodojt
^odcfrcnlo
Kdprivodojt
< -;% 4 0
-;% ti +;% 4 ?
31% ti +;;% 4 31
: +;;% 4 2
0
?
31
2
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
14/31
Witcl 8-Dkjuto Pclf Gkstcjbo
>51
>5?
>;1>;?
211
21?
231
Witcl 8-DPG
Qro
Qist
Cvorc`o Qro roecn= >;1 Dotors
Cvorc`o Qist roecn= 218 Dotors
(Gkhhorojbo= +38 Dotors ir +5%)
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
15/31
Qro & Qist roecn Witcl 8-DPG
Gkhhorojbo ny %
Goblkjo
Ji Becj`o
Kdprivodojt
^odcrfcnlo
Kdprivodojt
< -? % 4 >-? % ti +? % 4 37
: +? % ti +7; % 4 5
:+7; % 4 3
>
37
5
3
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
16/31
Witcl judnor ih rost tcfoj
1
?
31
3?
>1
^ost
Qro
Qist
Qro roecn= 35 Cvorc`o= 1.0
Qist roecn= 31 Cvorc`o= 1.7
(Gkhhorojbo= -5 ir +?8%) www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
17/31
Pects teo Rtcjgcrgs 9
*Blcugkbctkij gkstcjbo kdprivodojt ny 30;%.
*Witcl wclfkj` gkstcjbo kdprivodojt ny 3>>%.(Hir cpprix 28 sosskijs ih suporvksog oxorbkso)
Rkdklcr rohlobtkij ij teo P.K.S. quostkijjckro
bidpcrog ti teo 8-DPW rosults.
(*@crgjor CP ot cl 3;;?,*Rbeckjholg ^D >113 , ^o`ojstokjor M@ ot cl 3;;1 & Wsck MB ot cl >11>)www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
18/31
Pects teo ^osult 9
Blcugkbctkij gkstcjbo
kdprivodojt 4 >7%
Witcl wclfkj` gkstcjbo
kdprivodojt 4 5%
(Hir 3> sosskijs ih
suporvksog oxorbkso)
Rkdklcr rohlobtkij ij teoP.K.S quostkijjckro
bidpcrog ti teo 8-
DPW iutbido 4 ?1%
Qrogkbtog 28 sosskijs
rosult
Blcugkbctkij gkstcjbo
kdprivodojt 4 0> %
Witcl wclfkj` gkstcjbo
kdprivodojt 4 >7 %
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
19/31
Cjclysks ih Gctc
1
>1
71
81
51
311
3>1
371
381
351
Blcugkbctkij
Gkstcjbo
Witcl 8-DPG P.K.S
Rtcjgcrgs
^osult
Qrogkbtog
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
20/31
Cjy Kdprivodojt 9
[os, sk`js ih kdprivodojt woro jitog cs
Rtowcrt FM ot cl >11> stctos nojohkts ecvo
nooj insorvog cs ocrly cs hiur woofs.
Nut rosults woro jit up ti teo stcjgcrgs
dojtkijog.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
21/31
Pey Reirthcll 9 (Gurctkij)
Gurctkij= Xory seirt gurctkij, oxblugkj` teo
hkrst & teo lcst sosskijs ijly skx woofs ih twi
sosskijs por woof.
Ovkgojbo su``ost dkjkdud ih teroo dijtes
wkte teroo sosskijs por woof.
(Loj` @B ot cl >111, Ekrsbe CW ot cl >118)www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
22/31
Pey Reirthcll 9 (Lovol ih Oxorbkso)
Lovol ih oxorbkso= Dklg lovol ih oxorbkso.
Qcpors usog kjtordkttojt trocgdkll wclfkj` ti
dcxkdcl tilorcjbo lovol ih pckj hir cpprix 21
ti 7? dkjutos por sosskij. (Ekctt P^ ot cl 3;;1 & 3;;7)
Weo cnivo ks jit prcbtkbcl, wekbe dcy locgs
ti loss bidplkcjt hrid teo pcrtkbkpcjts (Eujt G ot cl
3;;;) cjg ek`e gripiut rcto.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
23/31
Pey Reirthcll 9 (Qcrtkbkpcjts)
Kj dist stugkos pcrtkbkpcjts ecvo ecg ijly dklg
ti digorcto blcugkbctkij ijly.(Rtowcrt FO ot cl >11>)
Iur pcrtkbkpcjts woro wkte digorcto ir sovoro
blcugkbctkij cjg wkte dultkplo dinklkty lkdktkj`
hcbtirs.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
24/31
Pey Reirthcll 9 (8-DPW)
Guo ti tkdo hcbtir ujcnlo ti gi Qro & Qist
roecn cssossdojt ijo porsij ct c tkdo cs
por teo `ukgolkjo.
Gkstrcbtkij ih teo oxcdkjoo ny teo iteor
pcrtkbkpcjts (dckjly gurkj` Qist roecn)
_jcnlo ti bijtril ojvkrijdojt hcbtirs ih teo
ecll (Wodporcturo & Eudkgkty lovol).
_skj` lits ih gkhhorojt oxcdkjors.
(CWR Rtctodojt >11>)www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
25/31
Pey Reirthcll 9 (S.i.L)
Ji ijo wclf wkte c ycrg stkbf (Qcrtkbkpcjts)
Ivor ir ujgor progkbt teokr iwj porhirdcjbo
(dckjly gurkj` Qro roecn) (Ojrk`et QL >112)
_.R ncsog Suostkijjckro. Weorohiro gkg how
digkhkbctkij ti sukto eoro.
Guo ti `oi`rcpey ih @ctoseocg dist ih teo
pcrtkbkpcjts stru``lo ti cjswor priporly.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
26/31
Pect wo ecvo cbekovog ny teo jow
Iutbido Docsuros 9
Ovkgojbo ncsog cjg dist cppriprkcto hir teks
`riup ih pctkojts.
Rojsktkvo, Rcho cjg Rkdplo.
Poll tilorctog ny teo pctkojts cjg bistohhobtkvo.
Cnlo ti billobt cjg cjclyso vcrkius gctc ct
ijo tkdo.Cnlo ti cssoss pctkojts porboptkij ih iteor
dinklkty lkdktkj` hcbtirs.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
27/31
Ru``ostkijs / ^obiddojgctkijs
Kjbrocskj` teo gurctkij ih teo `riup ny teroo
dijtes & teroo sosskijs por woof. (@crgjor CP ot cl3;;?, Loj` @B ot cl >111, Beibfclkj`cd Q >118)
^oplcbo teo roskstcjbo oxorbkso (Crd wok`ets,
Worcncjg) stctkijs wkte diro hujbtkijcl
oxorbkso. (Ekctt P^ ot cl 3;;7 & Rtowcrt FM ot cl >11>)
Dkjkdkskj` teo oxcdkjors. (CWR Rtctodojt >11>)
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
28/31
Ru``ostkijs / ^obiddojgctkijs
Ru``ostkj` pcrtkbkpcjts ti wirf ti teo lovol 2
ih pckj & ti teo porbokvog oxortkij lovol ih 7
ti ?. (@crgjor CP ot cl 3;;? & Loj` @B ot cl >111)
Bijbogor cltorkj` teo stcjgcrg ti libcl &
hocsknlo lovol hir hurteor cugkt guo ti vcst
gkhhorojbo cjg lkdktctkijs kj prcbtkbo
bidpcrog ti teo ovkgojbo.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
29/31
^ohorojbo
CWR Rtctodojt >11>= @ukgolkjos hir teo Rkx-Dkjuto Pclf Wost=Cdorkbcj
Miurjcl ih ^ospkrctiry cjg Brktkbcl Bcro Dogkbkjo Xil 388. pp. 333-330.
Nojgordcbeor NLP ot cl >1186 Ruporvksog Oxorbkso Weorcpy vorsus Jij-
Ruporvksog Oxorbkso Weorcpy hir Kjtordkttojt Blcugkbctkij6 Weo Bibercjo
Gctcncso ih Rystodctkb ^ovkows6 Kss->, Ji BG11?>82.pun>
Beibfclkj`cd Q >118= Q.C.G. Oxorbkso @riup Qctkojt Suostkijjckro &
Gibudojtctkij Cugkt= @ctoseocg Eoclte JER Hiujgctkij Wrust.
Ojrk`et QL ot cl >1126 Weo 8-dkj Pclf Wost= C Sukbf Docsuro ih Hujbtkijcl
Rtctus kj Olgorly Cgults. Beost6 Xil 3>26 Qc`o 250-2;5.
Ojrk`et QL >1126 Weo Rkx-Dkjuto Pclf Wost= ^osp Bcro6 Xil-75,Ji-5, 052-05?.
@crgjor CP ot cl 3;;?6 Oxorbkso ^oecnklktctkij Qri`rcds hir teo Wroctdojt ih
Blcugkbctkij Qckj= C Dotc-Cjclysks= MCDC6 Xil->07, Ji-3>, ;0?-;51.
Ekctt P^ ot cl 3;;16 Nojohkts ih Oxorbkso Bijgktkijkj` hir Qctkojts wkte
Qorkpeorcl Crtorkcl Gksocso6 Bkrbulctkij6 Xil-53, Ji->681>-81;.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
30/31
^ohorojbo
Ekctt P^ ot cl 3;;76 Ruporkirkty ih trocgdkll wclfkj` oxorbkso vorsus Rtroj`te
trckjkj` hir pctkojts wkte porkpeorcl crtorkcl gksocso. Kdplkbctkijs hir teo
dobecjksd ih teo trckjkj` rospijso= Bkrbulctkij6 Xil-;1, 3588-3507.
Ekctt P^ ot cl 3;;?6 Blkjkbcl Wrkcls hir Blcugkbctkij= Cssossdojt ih Oxorbkso
Qorhirdcjbo, Hujbtkijcl Rtctus, cjg Blkjkbcl Ojg Qikjts6 Bkrbulctkij6 ;>=837-
8>3. Ekrsbe CW ot cl >1186 CBB/CEC @ukgolkjos hir teo dcjc`odojt ih Qctkojts wkte
Qorkpeorcl Crtorkcl Gksocso (Liwor Oxtrodkty, ^ojcl, Dosojtrkb, cjg Cngidkjcl
Cirtkb)= Miurjcl ih teo Cdorkbcj Billo`o ih Bcrgkili`y6 Xil-70, Ji-8, 3>2;-323>.
Eujt G ot cl 3;;;6 Kjtordkttojt blcugkbctkij= Kdplodojtctkij ih cj oxorbkso
pri`rcddo. Wroctdojt ropirt6 Qeyskiteorcpy6 Xil-52, Ji-2, 37;-3?2.
Loj` @B ot cl >1116 Oxorbkso hir Kjtordkttojt Blcugkbctkij6 Weo Bibercjo
Gctcncso ih Rystodctkb ^ovkows6 Kss->, Ji= BG111;;1
Dijt`idory QR ot cl 3;;5= Weo Blkjkbcl utklkty ih c Rkx-Dkjuto Pclf Wost kj
Qorkpeorcl Crtorkcl Ibbluskvo Gksocso Qctkojts6 M Cdo @ork Ribkoty6 Xil- 78, Ji-
8, 018-033.
www.sbrkng.bid/bprcgeoop
-
8/14/2019 Peripheral Arterial Disease, Peripheral Vascular Disease
31/31
^ohorojbo
Ietcfo QM >11?6 Hkolg Wosts ih Corinkb Bcpcbkty hir Beklgroj cjg Ilgor Cgults6
Bcrgkipuldijcry Qeyskbcl Weorcpy Miurjcl6 Xil 38, J>2, Qc`o ?-33&71
^o`ojstokjor M@ ot cl 3;;16 Ovcluctkij ih Pclfkj` Kdpckrdojt ny Suostkijjckro
kj Qctkojts wkte Qorkpeorcl Crtorkcl Gksocso6 Miurjcl ih Xcsbulcr Dogkbkjo cjg
Nkili`y. Xil- >, Ji-2, Qc`o 37>-3?>.
Rbeckjholg ^D >113= Dcjc`odojt ih Qorkpeorcl Crtorkcl Gksocso cjgKjtordkttojt Blcugkbctkij6 M Cd Nicrg Hcd Qrcbt6 Xil-37. Ji-8, 772-77?.
Rbeoror RC >1176 ^osocrbe Birjor= Hujbtkijcl Iutbido Docsurodojts hir
Qctkojts wkte Qorkpeorcl Crtorkcl Gksocso6 Bcrgkipuldijcry Qeyskbcl Weorcpy
Miurjcl6 Xil 3?, Ji2, Qc`o >2->5.
Rtowcrt FM ot cl >11>6 Oxorbkso Wrckjkj` hir Blcugkbctkij6 Weo Jow Oj`lcjg
Miurjcl ih Dogkbkjo6 Xil-270, Kss->7, Qc`o 3;73-3;?3.
Wsck MB ot cl >11>6 Weo Ohhobts ih Oxorbkso Wrckjkj` ij Pclfkj` Hujbtkij cjg
Qorboptkij ih Eoclte stctus kj Olgorly Qctkojts wkte Qorkpeorcl Crtorkcl Ibbluskvo
Gksocso6 Miurjcl ih Kjtorjcl Dogkbkjo6 Xil >?>, Qc`o 775-7??